Literature DB >> 26114213

Improving assessment in small fiber neuropathy.

Brigitte A Brouwer1, Mayienne Bakkers2, Janneke G J Hoeijmakers2, Catharina G Faber2, Ingemar S J Merkies2,3.   

Abstract

Interval measures at the impairment level addressing symptoms and at the activity/participation level addressing daily and social restrictions have not been developed for small fiber neuropathy (SFN). We developed an SFN-specific Rasch-built overall disability scale (SFN-RODS©), an activity/participation scale at the interval level. A preliminary SFN-RODS containing 146 activity/participation items was assessed twice (reliability studies) in 238 patients with SFN. The ordinal-based 13-item SFN-symptoms inventory questionnaire (SFN-SIQ©) and pain-visual-analogue-scale were also assessed (validity studies). The pre-SFN-RODS and SFN-SIQ data were subjected to the Rasch analyses. The pre-SFN-RODS did not meet Rasch model expectations. Based on requirements, such as misfit statistics, differential item functioning, and local dependency, items were systematically removed and model fit improved. Finally, a 32-item SFN-RODS© scale was constructed that fulfilled all Rasch requirements, demonstrating acceptable reliability and validity scores. The 13-item SFN-SIQ© was successfully transformed to an interval Rasch-built measure fulfilling model's requirements. In conclusion, the 32-item SFN-RODS© is a disease-specific interval measure suitable for detecting activity limitations and participation restrictions in patients with SFN. The 13-item SFN-SIQ© was transformed through Rasch to an interval measure. The use of these scales is recommended in future clinical interventional trials involving patients with SFN.
© 2015 Peripheral Nerve Society.

Entities:  

Keywords:  Rasch-built overall disability scale; outcome research; peripheral neuropathy; small fiber neuropathy

Mesh:

Year:  2015        PMID: 26114213     DOI: 10.1111/jns.12128

Source DB:  PubMed          Journal:  J Peripher Nerv Syst        ISSN: 1085-9489            Impact factor:   3.494


  5 in total

1.  Intravenous immunoglobulin therapy for small fiber neuropathy: study protocol for a randomized controlled trial.

Authors:  Bianca T A de Greef; Margot Geerts; Janneke G J Hoeijmakers; Catharina G Faber; Ingemar S J Merkies
Journal:  Trials       Date:  2016-07-20       Impact factor: 2.279

Review 2.  Current View of Diagnosing Small Fiber Neuropathy.

Authors:  Lisette R M Raasing; Oscar J M Vogels; Marcel Veltkamp; Christiaan F P van Swol; Jan C Grutters
Journal:  J Neuromuscul Dis       Date:  2021

3.  Small Fiber Neuropathy in Sarcoidosis.

Authors:  Natalia Gavrilova; Anna Starshinova; Yulia Zinchenko; Dmitry Kudlay; Valeria Shapkina; Anna Malkova; Ekaterina Belyaeva; Maria Pavlova; Piotr Yablonskiy; Yehuda Shoenfeld
Journal:  Pathophysiology       Date:  2021-12-20

Review 4.  Corneal Confocal Microscopy in the Diagnosis of Small Fiber Neuropathy: Faster, Easier, and More Efficient Than Skin Biopsy?

Authors:  Mariia V Lukashenko; Natalia Y Gavrilova; Anna V Bregovskaya; Lidiia A Soprun; Leonid P Churilov; Ioannis N Petropoulos; Rayaz A Malik; Yehuda Shoenfeld
Journal:  Pathophysiology       Date:  2021-12-26

5.  Intravenous Immunoglobulin Therapy in Patients With Painful Idiopathic Small Fiber Neuropathy.

Authors:  Margot Geerts; Bianca T A de Greef; Maurice Sopacua; Sander M J van Kuijk; Janneke G J Hoeijmakers; Catharina G Faber; Ingemar S J Merkies
Journal:  Neurology       Date:  2021-03-25       Impact factor: 9.910

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.